Although an initial case series suggested that use of statins in pregnancy carried teratogenic risk, a recent meta-analysis of controlled observational studies has failed to corroborate this. A large number of potentially beneficial uses of statins in pregnant women have prompted a new evaluation of the risk-benefit ratio of these agents in pregnancy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/S1701-2163(15)30565-X | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!